Mark V Anquillare - 22 Nov 2021 Form 4 Insider Report for Verisk Analytics, Inc. (VRSK)

Signature
/s/ Kathy Card Beckles, Attorney-in-Fact
Issuer symbol
VRSK
Transactions as of
22 Nov 2021
Net transactions value
-$3,465,760
Form type
4
Filing time
22 Nov 2021, 16:19:12 UTC
Next filing
20 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRSK Common Stock Options Exercise $1,252,086 +20,479 +95% $61.14 41,981 22 Nov 2021 Direct
transaction VRSK Common Stock Sale $664,970 -2,900 -6.9% $229.30 39,081 22 Nov 2021 Direct F1
transaction VRSK Common Stock Sale $2,865,254 -12,436 -32% $230.40 26,645 22 Nov 2021 Direct F2
transaction VRSK Common Stock Sale $1,187,622 -5,143 -19% $230.92 21,502 22 Nov 2021 Direct F3
holding VRSK Common Stock 57,000 22 Nov 2021 By Trust F4
holding VRSK Common Stock 9,027 22 Nov 2021 By Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRSK Stock Option Options Exercise $0 -20,479 -50% $0.000000 20,480 22 Nov 2021 Common Stock 20,479 $61.14 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $228.73 to $229.69, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1).
F2 These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $229.74 to $230.71, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2).
F3 These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $230.75 to $231.26, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3).
F4 These shares of common stock are held by the Mark Anquillare Spousal Living Trust.
F5 These shares of common stock are held in a Revocable Trust.
F6 This stock option was granted under the Issuer's 2009 Equity Incentive Plan.
F7 Immediately.